University Venture Fund II

Sorenson Impact University Venture Fund Closes Blackrock Neurotech $10M Financing Round

University Venture Fund II has joined lead investor Christian Angermayer’s re.Mind Capital, an SPV sponsored by Peter Thiel, German entrepreneur Tim Sievers, and with investment advice from local investor LDD (Lead Dog Development) in closing a $10 million financing round for Blackrock Neurotech, the world’s leading platform for brain-computer interface (BCI) technology and manufacturing. “The impact Blackrock is making through BCI technology is transformative,” [...]

2021-05-26T09:49:54-06:00May 26th, 2021|
Read More

University Venture Fund II is first money in Navigen Pharmaceuticals seed round

SALT LAKE CITY—The Sorenson Impact Center’s University Venture Fund - Impact Investing (UVF II) closed its first investment in a seed round into Salt Lake City-based Navigen, Inc. UVF II’s investment was highly catalytic, unlocking over $1.5 million additional investment capital into the pharmaceutical company. Navigen, Inc. is an early-stage drug discovery and development company that has developed a D-peptide drug discovery platform to [...]

2018-10-03T12:41:30-06:00October 3rd, 2018|
Read More
Go to Top